Apple Tree Partners is a leading life sciences venture capital firm with global presence and reach that is developing the next generation of transformative biotechnology companies.

Founded in 1999, ATP today brings together over $2.5 billion assets under management (AUM), one of the sector’s most highly selective funding methodologies, and a seasoned team of venture partners to create a proven hub-and-spoke model for translation of emerging science into new medical treatments.

ATP works with the world’s most innovative life scientists and provides the capital, expertise, and operational intelligence to build new biopharmaceutical companies and drive long-term value.